The University of Chicago Header Logo

Connection

Abraham Dachman to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Abraham Dachman has written about Antibodies, Monoclonal.
Abraham Dachman
Connection Strength
0.009
Antibodies, Monoclonal
  1. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.